Wellington Management Group

Wellington Management Group Portfolio holdings

AUM $571B
1-Year Est. Return 22.15%
 

Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.

This Quarter Est. Return
1 Year Est. Return
+22.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$551B
AUM Growth
+$31.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,060
New
Increased
Reduced
Closed

Top Buys

1 +$1.77B
2 +$1.65B
3 +$1.47B
4
GILD icon
Gilead Sciences
GILD
+$1.13B
5
KR icon
Kroger
KR
+$1.03B

Top Sells

1 +$1.34B
2 +$1.23B
3 +$1.09B
4
AXP icon
American Express
AXP
+$999M
5
JPM icon
JPMorgan Chase
JPM
+$969M

Sector Composition

1 Technology 24.89%
2 Financials 15.95%
3 Healthcare 15.39%
4 Consumer Discretionary 9.68%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRV icon
1601
Acrivon Therapeutics
ACRV
$74.5M
$1.06M ﹤0.01%
888,130
DSGX icon
1602
Descartes Systems
DSGX
$7.08B
$1.05M ﹤0.01%
10,384
+27
ATXS icon
1603
Astria Therapeutics
ATXS
$722M
$1.04M ﹤0.01%
193,749
+41,138
GPN icon
1604
Global Payments
GPN
$17.9B
$1.03M ﹤0.01%
12,852
-372,371
LENZ
1605
LENZ Therapeutics
LENZ
$955M
$1.02M ﹤0.01%
34,827
+4,339
HRTX icon
1606
Heron Therapeutics
HRTX
$213M
$1.02M ﹤0.01%
493,083
+5,841
GLUE icon
1607
Monte Rosa Therapeutics
GLUE
$1.05B
$1.01M ﹤0.01%
224,818
+37,087
MLTX icon
1608
MoonLake Immunotherapeutics
MLTX
$973M
$1.01M ﹤0.01%
21,390
-10,773
CPRX icon
1609
Catalyst Pharmaceutical
CPRX
$2.88B
$1.01M ﹤0.01%
46,359
-2,088
ABEO icon
1610
Abeona Therapeutics
ABEO
$275M
$991K ﹤0.01%
174,514
+21,393
ICL icon
1611
ICL Group
ICL
$7.21B
$987K ﹤0.01%
143,929
-344,408
TYRA icon
1612
Tyra Biosciences
TYRA
$1.2B
$986K ﹤0.01%
103,078
-1,009
ELS icon
1613
Equity Lifestyle Properties
ELS
$12.2B
$980K ﹤0.01%
15,897
+293
GAP
1614
The Gap Inc
GAP
$10.1B
$979K ﹤0.01%
+44,891
ALT icon
1615
Altimmune
ALT
$549M
$975K ﹤0.01%
251,866
+26,912
ABSI icon
1616
Absci
ABSI
$477M
$972K ﹤0.01%
378,261
+55,142
OLMA icon
1617
Olema Pharmaceuticals
OLMA
$2.27B
$971K ﹤0.01%
228,021
-1,245,658
XLU icon
1618
Utilities Select Sector SPDR Fund
XLU
$22.5B
$965K ﹤0.01%
11,820
-35,032
CHE icon
1619
Chemed
CHE
$6.2B
$958K ﹤0.01%
1,967
-47
TRVI icon
1620
Trevi Therapeutics
TRVI
$1.69B
$941K ﹤0.01%
171,982
+44,530
AFYA icon
1621
Afya
AFYA
$1.37B
$932K ﹤0.01%
52,203
OPBK icon
1622
OP Bancorp
OPBK
$200M
$913K ﹤0.01%
70,299
CMPX icon
1623
Compass Therapeutics
CMPX
$1.03B
$905K ﹤0.01%
348,040
+125,535
FULC icon
1624
Fulcrum Therapeutics
FULC
$592M
$870K ﹤0.01%
+126,402
EWA icon
1625
iShares MSCI Australia ETF
EWA
$1.33B
$866K ﹤0.01%
+32,902